ArticleScientific reports2025
Evaluation on the clinical findings and allergological factors of local allergic conjunctivitis and non-local allergic conjunctivitis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sexual Dimorphism in Allergic and Mast Cell-Associated Diseases.Clinical reviews in allergy & immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We previously reported that 16.9% of allergic conjunctival disease cases were local allergic conjunctivitis (LAC). We therefore retrospectively investigated the pathological and clinical changes of LAC. Tear, conjunctival, and blood tests were performed on 313 patients with allergic conjunctival disease. A total of 313 patients with allergic conjunctival disease were surveyed using tear, conjunctival, and blood tests and QOL Questionnaire. In addition, we retrospectively examined the clinical test results of patients who agreed to re-examination more than one year after being diagnosed with LAC. Of the 313 cases, 44 were diagnosed as LAC (age ranged in 11-85 years (mean 67.8 years)) and 269 were diagnosed as non-LAC (7-92 years (mean 58.2 years)). There were 6 males (13.6%) and 38 females (86.4%), with more females even after age adjustment (p = 0.043). A QOL survey showed that LAC was characterized by less interference with daily life than non-LAC. After re-examination, 6 of 12 patients (50.0%) remained with LAC, while the remaining half changed to non-LAC. LAC was more common in older women than non-LAC. Considering the clinical change from LAC to non-LAC, it is speculated that the pathology of LAC may change over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.